Status of Disease Burden of Lower Urinary Tract Symptoms in Chinese Male Community
This study, set up as a cross-sectional survey, seeks to delve into the disease burden and the demographic specifics of lower urinary tract symptoms (LUTS) among the male community in China. The investigators's main aim is to map out the overall and age-specific prevalence rates of LUTS within the Chinese male populati
| Condition(s) | Lower Urinary Tract Symptoms |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study, set up as a cross-sectional survey, seeks to delve into the disease burden and the demographic specifics of lower urinary tract symptoms (LUTS) among the male community in China. The investigators's main aim is to map out the overall and age-specific prevalence rates of LUTS within the Chinese male population. These insights are critical for understanding the public health dimensions of this condition. Moreover, the investigators plan to investigate several secondary aspects: the correlation of LUTS prevalence with factors like urbanization levels (rural vs. urban), geographical distribution, and lifestyle choices. Another significant focus will involve examining the treatment landscape for LUTS, looking at the portion of sufferers receiving treatment, the diversity in treatmen |
| Who can participate | Inclusion Criteria: 1. Mainland China, aged 40 or older, male, in 31 provincial-level administrative regions. 2. Have resided for a total of 6 months or more in the survey county (district) in the past 12 months. 3. Normal communication, cooperation during physical examination, and good cognitive ability. 4. Willing to participate in and cooperate with this study, and sign the informed consent form. Exclusion Criteria: 1. Closed communities, such as armed forces and nursing homes. 2. Individuals with mental illnesses or other conditions that prevent cooperation. |
| Ages | 40 Years |
| Sex | Male |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Chinese PLA General Hospital |
| Locations | Beijing, China |
| Start date | 2023-06-01 |
| NCT ID | NCT06352736 |
| Official listing | https://clinicaltrials.gov/study/NCT06352736 |